FIELD: medicine.
SUBSTANCE: invention concerns medicine, namely oncology and can be used in estimation of clinical effectiveness factors in treatment of carcinoma of cervical stump. Daily urine is analysed for estradiol content and if decreased after treatment from initial level within 8.44-12.85 nmol/days, positive antineoplastic effect of treatment is stated, and if urine estradiol content is maintained in the treated patients within 8.81-11.38 nmol/days, the absence of antineoplastic effect is stated. The obtained results allow considering dynamics of estradiol content in daily urine of the patients suffering from carcinoma of cervical stump prior to AHCT as an additional laboratory test to estimate efficiency of presented pharmacotherapy. Observed positive clinical effect is confirmed by higher operability and improved life quality of the patients.
EFFECT: estimation of hormonal index earlier not detected to estimate clinical effectiveness of antineoplastic therapy.
1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PROVIDED EFFICIENCY OF NON-ADJUVANT AUTOHEMOCHEMOTHERAPY FOR PATIENTS SUFFERING FROM PAGET-TYPE BREAST CANCER | 2007 |
|
RU2328747C1 |
METHOD OF ESTIMATING EFFICIENCY OF TREATING PATIENTS WITH HODGKIN'S LYMPHOMA | 2009 |
|
RU2405451C1 |
METHOD OF PREDICTING CHEMORADIOTHERAPY EFFICIENCY IN PATIENTS WITH DISSEMINATED SKIN MELANOMA | 2008 |
|
RU2398238C1 |
METHOD FOR PREDICTION OF EFFECTIVENESS OF NEOADJUVANT AUTOMYELOCHEMOTHERAPY IN PATIENTS WITH RECURRENT BREAST CANCER | 2008 |
|
RU2393484C1 |
METHOD OF PREDICTING DURATION OF RECURRENCE-FREE PERIOD IN RADICALLY TREATED PATIENTS WITH MAMMARY GLAND CANCER | 2009 |
|
RU2413231C2 |
METHOD FOR PREDICTING EFFICIENCY OF TREATING PATIENTS WITH CERVICAL CANCER RECURRENCES | 2015 |
|
RU2618408C2 |
METHOD OF PREDICTING PROCESS GENERALISATION IN CASE OF MALIGNANT BONE TUMOURS | 2010 |
|
RU2427323C1 |
METHOD FOR PREDICTING INDIVIDUAL TUMOR SENSITIVITY TO CHEMOTHERAPY | 2000 |
|
RU2179725C2 |
METHOD FOR ESTIMATING ANTITUMOR THERAPY EFFECTIVENESS IN TREATING PATIENTS FOR OVARIAN CARCINOMA | 2005 |
|
RU2293329C2 |
METHOD FOR PREDICTION OF CLINICAL COURSE IN DISSEMINATED SKIN MELANOMA PATIENTS | 2008 |
|
RU2399057C1 |
Authors
Dates
2009-12-10—Published
2008-05-20—Filed